Literature DB >> 23059181

What is needed for phage therapy to become a reality in Western medicine?

Harald Brüssow1.   

Abstract

The current status of phage therapy approaches is reviewed and possible hurdles to a practical medical application of bacteriophages in Western countries are identified as discussed at a recent EMBO meeting on "Viruses of Microbes" in Brussels. In view of the growing antibiotic resistance crisis, a coordinated effort by the public health sector is needed to evaluate the potential of phage therapy as an adjunct to antibiotics.
Copyright © 2012 Elsevier Inc. All rights reserved.

Mesh:

Year:  2012        PMID: 23059181     DOI: 10.1016/j.virol.2012.09.015

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  55 in total

Review 1.  Viral interference of the bacterial RNA metabolism machinery.

Authors:  Tom Dendooven; An Van den Bossche; Hanne Hendrix; Pieter-Jan Ceyssens; Marleen Voet; K J Bandyra; Marc De Maeyer; Abram Aertsen; Jean-Paul Noben; Steven W Hardwick; Ben F Luisi; Rob Lavigne
Journal:  RNA Biol       Date:  2016-11-11       Impact factor: 4.652

2.  Bordetella bronchiseptica bateriophage suppresses B. bronchiseptica-induced inflammation in swine nasal turbinate cells.

Authors:  Ga Young Park; Hye Min Lee; Hyun Jin Yu; Jee Soo Son; Sang Joon Park; Kyoung Seob Song
Journal:  Genes Genomics       Date:  2018-10-23       Impact factor: 1.839

3.  Pasteurella multocida specific bacteriophage suppresses P. multocida-induced inflammation: identification of genes related to bacteriophage signaling by Pasteurella multocida-infected swine nasal turbinate cells.

Authors:  Ga Young Park; Hyun Jin Yu; Jee Soo Son; Sang Joon Park; Hee-Jae Cha; Kyoung Seob Song
Journal:  Genes Genomics       Date:  2019-12-18       Impact factor: 1.839

Review 4.  Phage therapy for respiratory infections.

Authors:  Rachel Yoon Kyung Chang; Martin Wallin; Yu Lin; Sharon Sui Yee Leung; Hui Wang; Sandra Morales; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2018-08-07       Impact factor: 15.470

5.  Alterations in gp37 Expand the Host Range of a T4-Like Phage.

Authors:  Mianmian Chen; Lei Zhang; Sheikheldin Adam Abdelgader; Li Yu; Juntian Xu; Huochun Yao; Chengping Lu; Wei Zhang
Journal:  Appl Environ Microbiol       Date:  2017-11-16       Impact factor: 4.792

6.  Phage Therapy: Future Inquiries.

Authors:  Sijia Wu; Elisabeth Zachary; Keenan Wells; Catherine Loc-Carrillo
Journal:  Postdoc J       Date:  2013-06

Review 7.  Implications of Bacteriophage- and Bacteriophage Component-Based Therapies for the Clinical Microbiology Laboratory.

Authors:  Katherine M Caflisch; Robin Patel
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

8.  Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections.

Authors:  Marine Henry; Rob Lavigne; Laurent Debarbieux
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

9.  Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing.

Authors:  Hiroki Ando; Sebastien Lemire; Diana P Pires; Timothy K Lu
Journal:  Cell Syst       Date:  2015-09-23       Impact factor: 10.304

10.  Isolation and Characterization of the Lytic Cold-Active Bacteriophage MYSP06 from the Mingyong Glacier in China.

Authors:  Mingyuan Li; Jilian Wang; Qi Zhang; Lianbing Lin; Anxin Kuang; Luis Alberto Materon; Xiuling Ji; Yunlin Wei
Journal:  Curr Microbiol       Date:  2016-02       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.